SO
THRD

STRS Ohio’s Third Harmonic Bio THRD Stock Holding History

STRS Ohio’s Portfolio THRD Stock Details THRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-42,400
Closed -$230K – 2287
2025
Q2 		$230K Buy
42,400
+3,000
+8% +$15K ﹤0.01% 1618
2025
Q1 		$137K Hold
39,400
– – ﹤0.01% 1592
2024
Q4 		$405K Hold
39,400
– – ﹤0.01% 1281
2024
Q3 		$534K Hold
39,400
– – ﹤0.01% 1227
2024
Q2 		$512K Buy
39,400
+3,900
+11% +$48.2K ﹤0.01% 1229
2024
Q1 		$335K Sell
35,500
-2,300
-6% -$22.4K ﹤0.01% 1409
2023
Q4 		$414K Buy
37,800
+34,900
+1,203% +$276K ﹤0.01% 1357
2023
Q3 		$18K Hold
2,900
– – ﹤0.01% 1879
2023
Q2 		$13K Hold
2,900
– – ﹤0.01% 1905
2023
Q1 		$11K Hold
2,900
– – ﹤0.01% 1895
2022
Q4 		$12K Buy
+2,900
New +$48.5K ﹤0.01% 1913

Other funds holding THRD

Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
CF
Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return
JC
JBF Capital Aspen, Colorado $676M AUM 24.74% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
AB
Amalgamated Bank New York $13.1B AUM 29.66% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
Optiver Holding
Optiver Holding Amsterdam, Netherlands $289B AUM 33.63% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

STRS Ohio's THRD Position: Q3 2025 in Review

STRS Ohio sold out of Third Harmonic Bio (THRD) in Q3 2025, closing a stake of 42,400 shares — an estimated $230K sold.

STRS Ohio first reported a position in THRD in Q4 2022 and held it in 11 quarters. The position peaked at $534K in Q3 2024. 18 funds tracked by Wall St. Rank hold THRD as of Q3 2025.

  • STRS Ohio reported no remaining Third Harmonic Bio position as of Q3 2025 after selling out during the quarter.
  • STRS Ohio sold 42,400 Third Harmonic Bio shares in Q3 2025, an estimated $230K.
  • STRS Ohio first reported a position in Third Harmonic Bio in Q4 2022 and held it in 11 quarters.
  • STRS Ohio's Third Harmonic Bio position peaked at $534K in Q3 2024.
  • 18 funds tracked by Wall St. Rank held Third Harmonic Bio as of Q3 2025.

Based on STRS Ohio's 13F filing for Q3 2025, filed 30 Oct 2025.